Oral Care to Prevent Ventilator-associated Pneumonia

Sponsor
Ataturk University (Other)
Overall Status
Completed
CT.gov ID
NCT05161962
Collaborator
(none)
57
1
2
5.2
11.1

Study Details

Study Description

Brief Summary

This study was conducted to investigate the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: One group received standard oral care.
  • Combination Product: It was applied to the other group by aspiration.
N/A

Detailed Description

The universe of this research, which was designed as a semi-experimental study, is composed of patients connected to the mechanical ventilator lying in Atatürk University Training and Research Hospital Anesthesia and Reanimation Intensive Care Unit between September 2019 and February 2020. A total of 57 patients, 29 method-1, 28 method-2 groups, met the inclusion criteria of the study. In the data collection phase, 'Patient Identifier Information Form', 'Patient Monitoring Form', 'Oral Assessment Scale' and 'Tracheal Aspirate Culture Result Form' were used. In the evaluation of the data, number and percentage distributions, Kruskal Wallis, Mann Withney-U, Wilcoxon Analysis, Chi-Square test were used.

Study Design

Study Type:
Interventional
Actual Enrollment :
57 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Investigation of the Effect of Oral Care Given by Two Different Methods in Patients Connected to Mechanical Ventilators on the Development of Ventilator-AssociatedPneumonia
Actual Study Start Date :
Sep 1, 2019
Actual Primary Completion Date :
Jan 23, 2020
Actual Study Completion Date :
Feb 5, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: One group received standard oral care.

Combination Product: One group received standard oral care.
the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.

Combination Product: It was applied to the other group by aspiration.
the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.

Placebo Comparator: It was applied to the other group by aspiration.

Combination Product: One group received standard oral care.
the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.

Combination Product: It was applied to the other group by aspiration.
the effect of oral care given by two different methods on the development of ventilator-associated pneumonia in patients connected to mechanical ventilators.

Outcome Measures

Primary Outcome Measures

  1. oral care application with standard oral care stick [1 in 6 hours]

    Administered with chlorhexidine gluconate solution.

  2. Oral care application with a sucking oral care stick [1 in 6 hours]

    Administered with chlorhexidine gluconate solution.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No

Inclusion Criteria:• Patients on mechanical ventilator who have been in intensive care for at least 48 hours

  • Male and female patients over the age of 18

  • Patients without thrombocytopenia, leukopenia and oral stomatitis, aphthae, candiasis, gingivitis

  • Patients whose respiratory support is provided by a mechanical ventilator

  • Patients who are considered to be able to provide mechanical ventilator support for 7 days

  • Patients without any respiratory-related infectious pathogens

  • Obtaining informed consent from the patient if he/she can give consent or from his/her guardian if he/she is unable to give consent.

  • It was determined as patients who did not undergo any intraoral surgical intervention.

Exclusion Criteria: patients with pneumonia Patients younger than 18 years

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 Atatürk University Erzurum Turkey

Sponsors and Collaborators

  • Ataturk University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ASENA KÖSE, research assistant, Ataturk University
ClinicalTrials.gov Identifier:
NCT05161962
Other Study ID Numbers:
  • AtaturkU-001
First Posted:
Dec 17, 2021
Last Update Posted:
Dec 17, 2021
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by ASENA KÖSE, research assistant, Ataturk University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 17, 2021